Inventor
BAUM ANKE
AT19 patents
⚠️ This page may combine multiple inventors who share the name “BAUM ANKE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM PHARMA
6 patentsUS7220750B2May 22, 2007
Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
BOEHRINGER INGELHEIM PHARMA71 citations98
US6861422B2Mar 1, 2005
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
BOEHRINGER INGELHEIM PHARMA115 citations98
US7750152B2Jul 6, 2010
Intermediate compounds for making dihydropteridinones useful as pharmaceutical compositions and processes of making the same
BOEHRINGER INGELHEIM PHARMA47 citations96
US8003786B2Aug 23, 2011
Dihydropteridinone compounds
BOEHRINGER INGELHEIM PHARMA34 citations95
US7786299B2Aug 31, 2010
Methods for treating diseases or conditions using dihydropteridinone compounds
BOEHRINGER INGELHEIM PHARMA19 citations91
US8586608B2Nov 19, 2013
Quinazoline derivatives and pharmaceutical compositions containing them
BOEHRINGER INGELHEIM PHARMA1 citations63
BOEHRINGER INGELHEIM INT
6 patentsUS7019012B2Mar 28, 2006
Quinazoline derivatives and pharmaceutical compositions containing them
BOEHRINGER INGELHEIM INT64 citations98
US7846936B2Dec 7, 2010
Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
BOEHRINGER INGELHEIM INT42 citations92
US7521457B2Apr 21, 2009
Pyrimidines as PLK inhibitors
BOEHRINGER INGELHEIM INT27 citations90
US7569561B2Aug 4, 2009
2,4-diaminopyrimidines useful for treating cell proliferation diseases
BOEHRINGER INGELHEIM INT11 citations83
US9539258B2Jan 10, 2017
Quinazoline derivatives for the treatment of cancer diseases
BOEHRINGER INGELHEIM INT2 citations71
US11814380B2Nov 14, 2023
Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors
BOEHRINGER INGELHEIM INT0 citations56